Jean-Michel Paradis
@Jmparadis27
Followers
90
Following
178
Media
0
Statuses
54
Interventional Cardiologist -Structural and Coronary Interventions - Quebec Heart and Lung Institute- Founder of Newton Medical
Québec, Canada
Joined April 2024
Another fantastic #TAVR live case transmitted from @IUCPQ at National Interventional Cardiologists Congress @SOCiME_ at Merida, Mexico. Great team work led by @Jmparadis27. Congratulations @Julio_Farjat for moderating the session at the other side. 📰 https://t.co/pjMrFz40XA
Live case of #SensorGuided (#SavvyWire #OpSens) #TAVI with 5th generation #Sapien3Ultra #RESILIA @EdwardsLifesci in Pure Severe #Aortic #Regurgitation, directly from #Quebec #Canada, my former not-so-long-ago home 🇨🇦🍁. Thanks and congrats to the fantastic operators and heart
0
2
6
Sim publication #GISE2024 🔈🔈 The Delayed atrioventricular block Prediction for eArly disChargE (D-PACE) score, consisting of procedural and electrocardiographic variables, can be used the day after transcatheter aortic valve implantation to stratify patients according to the
0
34
107
Live case of #SensorGuided (#SavvyWire #OpSens) #TAVI with 5th generation #Sapien3Ultra #RESILIA @EdwardsLifesci in Pure Severe #Aortic #Regurgitation, directly from #Quebec #Canada, my former not-so-long-ago home 🇨🇦🍁. Thanks and congrats to the fantastic operators and heart
3
3
14
Great technique to bail-out lost wire position in the LV during balloon-expandable TAVR using a 4-8 mm EN-snare through the delivery system. Nice! @ryankaple @CraigBasman A Microsnare Technique for Transcatheter Heart Valve Recrossing After Inadvertent Wire Withdrawal From Left
4
21
63
🚀 Want a front-row seat to cutting-edge research? Watch Dr. Michael Reardon give an exclusive first look at the ACURATE IDE trial set to be revealed on Wednesday, October 30. Experience first-time presentations of major clinical trials and groundbreaking science at #TCT2024!
0
11
31
🌟🙌6 presentations including clinical cases and abstract accepted for #PCRLV this year 🎉🌟 Thrilled to share my insights and dive into vibrant discussions with my peers in 🇬🇧London 24-26 November 2024! Can't wait for this an inspiring experience! #PCRPresenter
@IUCPQ 🇨🇦
3
3
10
Liberal ransfusion (target 10 g/dL) may save lives and prevent recurrent MI in type 1 MI! Important insights from the MINT trial. 🍃 @SimonTabassome @ShaunGoodman @herbaronowMD @gabrielsteg @SVRaoMD @Baystate_Health @Baystate_Cards @BaystateIM @UMassChan
#MINT trial analysis: Restrictive transfusion strategy may increase risk of death or MI in patients with type 1 myocardial infarction, while type 2 MI patients show no significant difference. @docjohanne @W66588221White @JDawnAbbott1 @AGoldsweig
https://t.co/ps59LLdu2m
0
9
39
Another positive signal for the use of TEER in FMR. It should be probably be considered early in this population alongside medications #ESC2024 #RESHAPEHF2
1
12
43
It’s about time! Come on @AHAScience @ACCinTouch… get with the guidelines!
🚨Breaking News: New ESC Guidelines on CCS. Intracoronary Imaging now Class IA for LM, true bifurcation and long lesions! Either OCT or IVUS. @PCRonline @escardio @NielsRHolm @twj1974 @nicolasamabile @FBiccire @ziadalinyc @hect2701 @sbrugaletta @HolgerNef
0
20
91
The first-in-human implantation of the A-Flux coronary sinus reducer, a novel device for treating refractory angina: this nitinol mesh device offers improved flow dynamics and repositionability compared to existing technologies. @Julio_Farjat
@Jmparadis27
https://t.co/anuucCxPA1
0
15
68
🚀 Get ready to shape the future of cardiovascular medicine at #TCT2024! Join us in D.C. for a transformative experience that will elevate your practice and enhance patient outcomes. ✨ Don't miss out—register now for the best rates! Prices go up on September 11. 👉
0
7
21
📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a selfexpanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more
0
1
3
📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a selfexpanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more
1
12
35
Kudos to Dr @Jmparadis27, Dr Alex Angers-Goulet, and the team at the Quebec Heart and Lung Institute (@IUCPQ) in Quebec City, Canada on their 1st randomized patient in the #COSIRAII trial! To learn more about the COSIRA-II trial and for a list of participating sites visit
0
2
24
Edwards Lifesciences buys JenaValve. Four acquisitions in a week
5
19
86
Want to learn more about transcatheter coronary sinus (CS) reducer technology? Watch this interview of author @Jmparadis27 by @Ortega_Paz! They discuss the recently published paper on the A-Flux CS reducer and the first-in-human experience. Access the paper below👇
0
6
13
A-Flux: a novel self-expanding coronary sinus reducer for refractory angina https://t.co/xAcnjuKAPm via @YouTube @EuroInterventio @PCRonline #CVRjax
0
3
6
How to retrieve your Prostyle when it gets stuck In challenging anatomies, the Prostyle may get stuck due to calcification, leading to urgent vascular surgery and increasing the operative risk for the patients. This #MyToolKit 🧰⚙️🪛 tutorial shows a step-by-step bailout
0
60
158
Very few have done so much for the field! Congrats @JWMoses @KambisMashayek1 @RinfretStephane @OPCILive @DrAllenJ @ESHLOF @djc795 @StFrancis_LI
MLCTO Career Achievement award to the one and only master Jeff Moses @MLCTOacademy @rinfretstephane
#pci #cto @KambisMashayek1 @OPCILive @ziadalinyc
0
2
48